×
GETINGE Price to Free Cash Flow Ratio 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GETINGE price to free cash flow ratio from 2016 to 2024. Price to free cash flow ratio can be defined as
View More
GETINGE Price to Free Cash Flow Ratio 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GETINGE price to free cash flow ratio from 2016 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$160.9B
Elevance Health (ELV)
$91.8B
Cencora (COR)
$49.1B
Natera (NTRA)
$23.4B
DiDi Global (DIDIY)
$22.6B
ICON (ICLR)
$16.4B
Revvity (RVTY)
$15.4B
Avantor (AVTR)
$15.2B
BioMerieux (BMXMF)
$14.4B
Viatris (VTRS)
$13.5B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.8B
Doximity (DOCS)
$11B
Medpace Holdings (MEDP)
$10.9B
EUROFINS SCIENT (ERFSF)
$10.4B
HealthEquity (HQY)
$9.6B
Charles River Laboratories (CRL)
$8.4B
Sonic Healthcare (SKHHY)
$8.3B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$6.1B
BrightSpring Health Services (BTSG)
$4.1B
Organon (OGN)
$4B
Sotera Health (SHC)
$3.9B
Surgery Partners (SGRY)
$3.2B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$3B
PACS (PACS)
$2.2B
Premier (PINC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
GeneDx Holdings (WGS)
$2.1B